海创药业(688302) - 2023 Q3 - 季度财报

Financial Performance - Total revenue for the third quarter was 0, with a year-to-date net profit attributable to shareholders of -238,045,630.34 RMB, representing a significant loss[6] - The net profit for the third quarter was -72,845,638.63 RMB, and the net profit excluding non-recurring gains and losses was -79,476,832.71 RMB[6] - Basic earnings per share for the third quarter were -0.74 RMB, with a year-to-date figure of -2.40 RMB[7] - The weighted average return on net assets was -5.09% for the third quarter, compared to -15.93% year-to-date[7] - Net loss for the first three quarters of 2023 was $238,045,630.34, compared to a net loss of $222,529,559.21 in the same period of 2022, indicating a worsening of approximately 6.9%[25] - The total comprehensive income attributable to the parent company for Q3 2023 was -237,915,875.73 RMB, compared to -222,383,316.40 RMB in Q3 2022, indicating a decline of approximately 6.5% year-over-year[26] - Basic earnings per share for Q3 2023 were -2.40 RMB, slightly improved from -2.48 RMB in Q3 2022[26] Cash Flow and Liquidity - The cash flow from operating activities for the year-to-date period was -200,389,992.91 RMB[7] - The net cash flow from operating activities for the first three quarters of 2023 was -200,389,992.91 RMB, compared to -191,333,995.01 RMB in the same period of 2022, reflecting a worsening of about 4.5%[29] - The total cash outflow from operating activities for the first three quarters of 2023 was 221,550,526.07 RMB, compared to 206,439,212.04 RMB in the same period of 2022, reflecting an increase of approximately 7.3%[29] - The cash and cash equivalents at the end of Q3 2023 stood at 738,499,433.74 RMB, compared to 273,176,166.15 RMB at the end of Q3 2022, indicating a year-over-year increase of approximately 170.5%[30] - The company's cash and cash equivalents amounted to approximately ¥738.54 million, a decrease from ¥1.20 billion as of December 31, 2022[17] - The company's cash and cash equivalents decreased to $17,978,049.74 from $17,080,401.06, a decline of about 5.3%[19] Assets and Liabilities - Total assets decreased by 9.18% from the previous year, amounting to 1,575,725,832.53 RMB[7] - Total liabilities increased to $171,591,213.25 from $149,682,536.17, representing a growth of about 14.3%[20] - The company's total equity decreased to $1,404,134,619.28 from $1,585,391,913.28, a decline of approximately 11.4%[20] - Total equity attributable to shareholders decreased by 11.43% to 1,404,134,619.28 RMB[7] - The company's inventory was recorded at ¥4,408.13 as of September 30, 2023, compared to ¥6,480.11 in the previous year[17] Research and Development - Research and development expenses for the third quarter were 58,779,233.60 RMB, a decrease of 10.69% compared to the previous year, while year-to-date R&D expenses increased by 10.28% to 206,756,960.85 RMB[7] - Research and development expenses rose to $206,756,960.85 from $187,483,803.35, an increase of about 10.3% year-over-year[24] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 3,682[12] - The top shareholder, Chengdu Yingchuang Power Venture Capital Co., held 10,518,476 shares, representing a significant portion of the company's equity[14] - The company has not reported any significant changes in its shareholder relationships or agreements beyond those disclosed[14] - The company has not engaged in any financing or securities lending activities involving its top shareholders during the reporting period[14] Corporate Governance - The company adjusted its board of directors from 9 members to 7 members to optimize governance structure and improve operational efficiency[15] - The company completed the election of the second board of directors and supervisory board, along with the appointment of a new management team during the reporting period[16] Other Financial Activities - The company reported non-recurring gains of 19,143,988.04 RMB for the year-to-date period[10] - The company reported a prepayment amount of approximately ¥37.46 million, up from ¥24.70 million in the previous year[17] - The company received tax refunds amounting to 10,043,239.33 RMB in Q3 2023, compared to 6,031,852.77 RMB in Q3 2022, marking an increase of about 66.5%[29] - The company reported a cash inflow of 500,000.00 RMB from financing activities in Q3 2023, a decrease from 1,010,104,941.40 RMB in Q3 2022[30] - Cash inflows from investment activities totaled 3,953,109,318.34 RMB in the first three quarters of 2023, up from 2,683,237,040.76 RMB in the same period of 2022, representing an increase of approximately 47.4%[29] - The net cash flow from investment activities for the first three quarters of 2023 was -261,253,681.58 RMB, an improvement from -1,436,101,968.63 RMB in the same period of 2022[29] - The net cash flow from financing activities for Q3 2023 was -4,271,894.80 RMB, a significant decrease compared to a positive net cash flow of 989,627,675.95 RMB in Q3 2022[30]